LABIOTECH.fr: Acticor Biotech wins its crowdfunding bet!

Acticor Biotech réussi le pari du crowdfunding!

By Joachim – Published on January 29, 2015 | LABIOTECH.fr

Read in English : Biotech’s crowdfunding: is France top of the class?

In France, you can feel a real enthousiasme for crowdfunding and many projects are running on different platforms. I met several companies currently fundraising to understand their reasons and issues. The first of these, Acticor Biotech, develops an antibody inhibitor of arterial thrombosis, directed against the glycoprotein 6 (GP6), a new therapeutic target on the surface of platelets.[…]

• Read Full article in English

Read next in 'Media Coverage'

• ACT017 : un fragment d’anticorps dont l’ACTion antithrombotique est prometteuse !
• Novel antiplatelet could circumvent bleeding risk for stroke patients
• Experimental antiplatelet compound for acute stroke shows promise
• New drug to prevent clots clears safety hurdle
• New blood thinner may prevent stroke, without risk for bleeding